Nunzia Pharmaceutical Company Stock price

Equities

NUNZ

US67097W1027

Pharmaceuticals

Market Closed - OTC Markets 08:10:00 2023-12-01 pm EST 5-day change 1st Jan Change
0.003 USD -.--% Intraday chart for Nunzia Pharmaceutical Company -.--% -.--%
Sales 2020 - Sales 2021 - Capitalization 170M
Net income 2020 -9M Net income 2021 -78M EV / Sales 2020 -
Net cash position 2020 * - Net Debt 2021 97.31K EV / Sales 2021 -
P/E ratio 2020
-94.8 x
P/E ratio 2021
-2.54 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 18.04%
More Fundamentals * Assessed data
Dynamic Chart
Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Nunzia Pharmaceutical Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt CI
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt CI
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Nunzia Pharmaceutical Corporation Announces Offering of Patented Blood Warmer Through Medical Supply Division CI
Nunzia Pharmaceutical Corporation Signs A Licensing Agreement with Michael Mitsunaga CI
Global WholeHealth Partners Corporation acquired distribution and selling rights of Moderna Vaccine of Nunzia Pharmaceutical Corporation. CI
Global Wholehealth Partners Corporation Partners with Nunzia Pharmaceutical Inc. to Distribute and Sell the Pfizer-BioNTech COVID-19 Vaccine CI
Global Wholehealth Partners Corporation Grants the Rights from Nunzia Pharmaceutical Inc. to Distribute and Sell the Johnson & Johnson Covid-19 Vaccine CI
Global Wholehealth Partners Corp. Partners with Nunzia Pharmaceutical Inc., Opening New Avenues of Revenue and Products for Global CI
Global Wholehealth Partners Corporation Enters into Mutual Sales and Marketing Agreement with Nunzia Pharmaceutical Inc CI
More news
1 year
0.00
Extreme 0.003
0.06
3 years
0.00
Extreme 0.003
4.00
5 years
0.00
Extreme 0.003
331.65
10 years
0.00
Extreme 0.003
331.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 -
President 68 08-12-31
Chief Tech/Sci/R&D Officer 62 19-12-04
Members of the board TitleAgeSince
President 68 08-12-31
Chief Tech/Sci/R&D Officer 62 19-12-04
Chief Executive Officer 51 -
More insiders
Nunzia Pharmaceutical Corporation is a pharmaceutical company. The Company focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The Company has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.
More about the company
  1. Stock
  2. Equities
  3. Stock Nunzia Pharmaceutical Company - OTC Markets